A great trip to Vienna for the excellent #ERA25 and back to London in time for Robbie at the Emirates last night - what a week!

Interesting talk about fragility of AAV studies - average number of patients in whom a change in event occurrence would change the overall outcome of study is just 4 (which is less than the number of patients who are lost to follow up). #ERA25

Stimulating session on frailty and renal transplantation #ERA25 Plenty to think about and implement in the clinic

This was a fun article to work on. Hope you enjoy it. Things We Do for No Reason™: Avoiding IV iodinated contrast material in patients with acute kidney injury or chronic kidney disease Journal of Hospital Medicine shmpublications.onlinelibrary.wiley.com/doi/10.1002/...

www.ukkidney.org/about-us/new... Really valuable work from ukka.

Bolus or infusion of iv furosemide? I’ve always felt that twice a day bolus is more effective but am seeing increasing use of infusions in patients under cardiology and acute medicine.

Does anyone advise patients on deceased donor renal transplant list not to take SGLT-2 inhibitors? Seems reasonable for living donor transplant to stop pre-op but not aware of risk : benefit in those waiting for deceased donor kidney?